Infantile digital fibromatosis
in-fan-tile dij-i-tal fy-bro-ma-toe-sis
Also known as: inclusion body fibromatosis, Reye tumor
At a Glance
What is Infantile digital fibromatosis?
Infantile digital fibromatosis is a rare condition characterized by the development of fibrous tumors on the fingers and toes of infants. These tumors primarily affect the skin and soft tissues of the digits. The exact cause of this condition is unknown, but it is not considered to be inherited. Over time, the tumors may grow but often stabilize or regress spontaneously. Early symptoms include small, firm nodules on the fingers or toes, which may increase in size. Late symptoms can involve discomfort or difficulty with movement if the tumors become large. Early diagnosis is important to differentiate these tumors from other potentially harmful conditions. The condition can be stressful for families due to concerns about potential impacts on hand or foot function. However, the prognosis is generally good, as the tumors are benign and often resolve without treatment. Daily life for affected individuals is usually normal, although monitoring by a healthcare provider is recommended. Surgical intervention is rarely needed unless the tumors cause functional impairment. Overall, the condition is benign and self-limiting, with minimal long-term impact on the child's health.
Infantile digital fibromatosis Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
These lesions typically present as firm, pink nodules on the dorsal or lateral aspects of the fingers. They are caused by the proliferation of myofibroblasts within the dermis. Over time, the nodules may increase in size and number, potentially leading to discomfort. Daily activities such as grasping objects can become challenging, and surgical excision may be considered if they interfere significantly with function.
Swelling occurs as a result of the underlying fibrous tissue growth within the fingers. This biological process involves the accumulation of collagen and other extracellular matrix components. As the condition progresses, the swelling can become more pronounced and persistent. It can hinder fine motor skills and may require interventions like physical therapy to maintain mobility.
The fibromatosis can lead to a restriction in the movement of the affected fingers. This is due to the fibrous tissue contracting and affecting the tendons and joints. Over time, the limitation in movement can worsen, potentially leading to joint stiffness. Patients may need to adapt their daily activities and engage in exercises to preserve joint function.
Common
Pain or tenderness may be experienced in the areas where the nodules are present. This is primarily due to the pressure exerted by the growing fibrous tissue on surrounding nerves. As the nodules enlarge, the discomfort can become more noticeable, especially during activities that involve finger use. Pain management strategies, including analgesics or local therapies, may be necessary to alleviate symptoms.
The skin overlying the nodules may appear reddish or purplish. This discoloration is due to increased vascularity and changes in the dermal tissue associated with the fibromatosis. It may persist or change as the condition evolves. While it is generally not painful, it can be a cosmetic concern for some patients, who might seek dermatological advice.
The presence of nodules and associated swelling can impair the ability to grip objects effectively. This difficulty arises from the mechanical obstruction and discomfort caused by the fibrous growths. Over time, this can lead to frustration and a decrease in the ability to perform tasks requiring fine motor skills. Occupational therapy may be beneficial in developing adaptive techniques to manage this symptom.
Less Common
In rare cases, the nodules may ulcerate, leading to open sores on the skin. This occurs when the skin over the nodules becomes thin and breaks down due to pressure or friction. Ulceration can increase the risk of infection and may require wound care management. Preventive measures include protecting the skin from trauma and monitoring for signs of infection.
The presence of open sores or ulcerated nodules can lead to secondary bacterial infections. These infections occur when bacteria penetrate the compromised skin barrier. If untreated, they can cause increased pain, redness, and swelling, potentially spreading to adjacent tissues. Prompt medical treatment with antibiotics and proper wound care is essential to manage infections effectively.
What Causes Infantile digital fibromatosis?
Infantile digital fibromatosis is not linked to a specific gene mutation, but rather is considered a benign fibrous proliferation of myofibroblasts. The normal function of myofibroblasts involves wound healing and tissue repair, where they contract and produce extracellular matrix components. In infantile digital fibromatosis, there is an abnormal proliferation of myofibroblasts, leading to the formation of fibrous nodules on the fingers and toes. This proliferation disrupts normal tissue architecture, causing the accumulation of actin filaments and dense bodies within the cells. The immediate molecular consequence is the excessive production of collagen and fibronectin, which are key components of the extracellular matrix. This leads to the dysfunction of the surrounding tissue structure, as the excessive fibrous tissue can compress and displace normal cells. The condition does not typically involve neuroinflammation or immune response, as it is a localized fibrous disorder. There is no degeneration of white matter or other structures, as the condition is confined to the skin and subcutaneous tissue of the digits. Symptoms appear in a specific pattern due to the localized nature of the myofibroblast proliferation, often affecting the fingers and toes of infants. The nodules are typically painless and do not impair function, which is why they may go unnoticed initially. Disease severity can vary between patients, with some experiencing spontaneous regression of the nodules while others may have persistent growth. The variability in severity is not well understood but may be influenced by individual differences in tissue response and myofibroblast activity. Overall, infantile digital fibromatosis is a benign condition with a generally favorable prognosis, although surgical intervention may be required in cases where the nodules interfere with function.
How is Infantile digital fibromatosis Diagnosed?
Typical age of diagnosis: Infantile digital fibromatosis is typically diagnosed in the first year of life, often shortly after birth, when characteristic nodules appear on the fingers or toes. Parents or pediatricians usually notice these firm, pink nodules during routine examinations or when the infant shows discomfort. The condition is rare, so awareness among healthcare providers is crucial for early identification. Diagnosis is primarily clinical, supported by imaging and, in some cases, histopathological examination.
Clinicians look for firm, pink nodules on the fingers or toes, often appearing symmetrically. A detailed history is taken to rule out trauma or other causes of nodules. Physical examination reveals non-tender, smooth nodules that do not ulcerate or discharge. This step helps differentiate from other soft tissue tumors and guides further diagnostic testing.
Ultrasound is the preferred imaging modality to assess the soft tissue nature of the nodules. It shows well-defined, hypoechoic lesions without calcifications, supporting the diagnosis. MRI can further delineate the extent and exclude deep tissue involvement. Imaging helps exclude differential diagnoses like vascular malformations or malignant tumors.
Routine laboratory tests are generally not specific for this condition. No biomarkers are uniquely associated with infantile digital fibromatosis. Abnormal results are not typical, but tests may be done to rule out systemic conditions. Laboratory findings guide the exclusion of other systemic diseases that may present with similar nodules.
Genetic testing is not typically required as there are no known specific genetic mutations associated with this condition. However, if a hereditary pattern is suspected, sequencing of genes involved in fibromatosis may be considered. Negative results do not exclude the diagnosis but can provide reassurance to the family. Genetic counseling may be offered to discuss the rarity and recurrence risk.
Infantile digital fibromatosis Treatment Options
Corticosteroids are sometimes used to reduce inflammation and nodule size. They work by suppressing the immune response and reducing fibroblast proliferation. Topical or intralesional corticosteroids may be applied, though evidence for efficacy is limited. Clinical trials are scarce, and results are variable, with some nodules regressing spontaneously without treatment. Side effects include skin atrophy and potential systemic absorption, especially in infants.
Physical therapy focuses on maintaining joint mobility and preventing contractures. Techniques include gentle stretching and range of motion exercises tailored to the child's age and development. Sessions are typically conducted weekly, with daily exercises recommended at home. Measurable outcomes include improved finger or toe function and prevention of deformities. Long-term benefits include preserved mobility and reduced need for surgical intervention.
Surgery is indicated when nodules cause functional impairment or significant discomfort. The procedure involves excising the fibromatous tissue while preserving surrounding structures. Expected benefits include immediate relief of symptoms and improved function. Surgical risks include recurrence, scarring, and potential damage to nerves or tendons. Post-operative care involves wound management and physical therapy to maintain function.
A team comprising dermatologists, pediatricians, surgeons, and physical therapists provides comprehensive care. Interventions include regular monitoring, education on condition management, and psychosocial support. Strategies focus on reducing anxiety and providing coping mechanisms for families. Education covers condition prognosis, treatment options, and home care strategies. Long-term monitoring ensures early detection of complications or recurrence.
When to See a Doctor for Infantile digital fibromatosis
- Sudden increase in size of the fibroma — this may indicate aggressive growth requiring immediate medical evaluation.
- Severe pain in the affected digit — could suggest nerve involvement or secondary infection.
- Signs of infection such as redness, warmth, or pus — these require urgent medical attention to prevent complications.
- Persistent swelling in the affected area — may need assessment to rule out complications.
- Limited mobility of the digit — could indicate worsening condition and may need intervention.
- Recurrent fibroma after removal — suggests the need for further evaluation and possibly different treatment.
- Mild discomfort in the affected digit — monitor for any changes in size or pain.
- Occasional stiffness in the finger — keep track of any progression and maintain range of motion exercises.
Infantile digital fibromatosis — Frequently Asked Questions
Is this condition hereditary?
Infantile digital fibromatosis is not typically considered hereditary. The probability of passing it to children is low as it usually occurs sporadically. De novo mutations are possible but not well-documented in this condition. Carrier status is not applicable as it is not a genetic disorder with a known inheritance pattern. Genetic counseling is generally not necessary but can be considered for reassurance.
What is the life expectancy for someone with this condition?
Life expectancy is generally normal as infantile digital fibromatosis is benign. Prognosis is favorable regardless of age of onset, though early treatment can improve outcomes. Mortality is not associated with this condition as it does not affect vital organs. Treatment can alleviate symptoms but does not impact survival. Realistic expectations include possible recurrence but manageable symptoms.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves clinical examination and sometimes biopsy to confirm fibromatosis. The time from first symptoms to diagnosis can vary, often taking weeks to months. Dermatologists or pediatricians are typically consulted for diagnosis. Delayed diagnosis may occur due to the rarity of the condition and its benign nature. Biopsy findings of characteristic inclusion bodies confirm the diagnosis.
Are there any new treatments or clinical trials available?
Current research focuses on less invasive treatments and understanding the condition's pathogenesis. Gene therapy is not applicable, but novel pharmacological approaches are being explored. Clinical trials can be found on ClinicalTrials.gov by searching for 'infantile digital fibromatosis'. Discussing trial eligibility and potential benefits with your doctor is recommended. New treatments may take several years to become widely available.
How does this condition affect daily life and activities?
The condition may cause discomfort and limit fine motor skills, affecting daily activities. It generally does not impact education but may require adaptations for writing or typing. Social and emotional challenges can arise from visible lesions, especially in children. Family burden is typically low but may involve managing appointments and treatments. Supportive footwear or gloves and physical therapy can help manage symptoms.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Infantile digital fibromatosis.
Heymann WR · J Am Acad Dermatol · 2008 · PMID: 18571599
- 2.Infantile Digital Fibromatosis.
Özdemir ZC, Töret E · Indian Pediatr · 2021 · PMID: 34837378
- 3.Infantile Digital Fibromatosis/Inclusion Body Fibromatosis: A Comprehensive Literature Review.
Godse R, Dany M, Tamazian S et al. · Skin Appendage Disord · 2023 · PMID: 36632366
- 4.Congenital infantile digital fibromatosis: a case report and review of the literature.
Adegoke OO, Ajao AE, Ano-Edward GH · Afr Health Sci · 2020 · PMID: 34394250
- 5.Infantile Digital Fibromatosis: Primum Non Nocere.
Rodríguez-Lomba E, Lozano-Masdemont B, Campos-Domínguez M · Actas Dermosifiliogr · 2022 · PMID: 35623736
- 6.[Infantile digital fibromatosis].
Badri T, Zaouak A, Koubaa W et al. · Ann Dermatol Venereol · 2014 · PMID: 24635964
- 7.Infantile digital fibromatosis: A clinical case report.
Romero Bravo M, Llamas Carmona JA, Gómez Moyano E et al. · An Pediatr (Engl Ed) · 2025 · PMID: 40158895
- 8.Therapeutic management of infantile digital fibromatosis.
Greco V, Annunziata MC, Scalvenzi M et al. · Ital J Dermatol Venerol · 2024 · PMID: 38695598
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-18